John P. Rooney

John P. Rooney

Auto-generated profile, based on publicly available information

John P. Rooney

Nicholas School of the Environment, Duke University, Durham, North Carolina

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2013 in Toxicological Sciences
Verified
Journal Article
Open access
PDF file
JMJoel N. Meyer
Joel N. Meyer
MLMaxwell C. K. Leung
Maxwell C. K. Leung
JRJohn P. Rooney
John P. Rooney
ASAtaman Sendoel
Ataman Sendoel
MHMichael O. Hengartner
Michael O. Hengartner
ABAmanda S. Bess
Amanda S. Bess
Enormous strides have recently been made in our understanding of the biology and pathobiology of mitochondria. Many diseases have been identified as caused by mitochondrial dysfunction, and many pharmaceuticals have been identified as previously unrecognized mitochondrial toxicants. A much smaller but growing literature indicates that mitochondria are also targeted by environmental pollutants. We briefly review the importance of mitochondrial function and maintenance for health based on the genetics of mitochondrial diseases and the toxicities resulting from pharmaceutical exposure. We then discuss how the principles of mitochondrial vulnerability illustrated by those fields might apply to environmental contaminants, with particular attention to factors that may modulate vulnerability including genetic differences, epigenetic interactions, tissue characteristics, and developmental stage. Finally, we review the literature related to environmental mitochondrial toxicants, with a particular focus on those toxicants that target mitochondrial DNA. We conclude that the fields of environmental toxicology and environmental health should focus more strongly on mitochondria.

22 September 2014
Verified
Book Chapter
Closed access
PDF file
JRJohn P. Rooney
John P. Rooney
IRIan T. Ryde
Ian T. Ryde
LSLaurie H. Sanders
Laurie H. Sanders
EHEvan. H. Howlett
Evan. H. Howlett
MCMeryl D. Colton
Meryl D. Colton
JMJoel N. Meyer
Joel N. Meyer

1 December 2007 in Molecular Cell
Verified
Journal Article
Closed access
UBUlrike Begley
Ulrike Begley
MDMadhu Dyavaiah
Madhu Dyavaiah
APAshish Patil
Ashish Patil
JRJohn P. Rooney
John P. Rooney
DDDan DiRenzo
Dan DiRenzo
TBThomas Begley
Thomas Begley

23 November 2004 in Neurology
Verified
Journal Article
Closed access
PDF file
JHJoseph J. Higgins
Joseph J. Higgins
JPJoanna Pucilowska
Joanna Pucilowska
RLRoni Q. Lombardi
Roni Q. Lombardi
JRJohn P. Rooney
John P. Rooney
Background: Identifying the genetic factors that contribute to memory and learning is limited by the complexity of brain development and the lack of suitable human models for mild disorders of cognition. Methods: Previously, a disease locus was mapped for a mild type of nonsyndromic mental retardation (IQ between 50 and 70) to a 4.2-MB interval on chromosome 3p25-pter in a large kindred. The genes and transcripts within the candidate region were systematically analyzed for mutations by single-strand polymorphism analysis and DNA sequencing. Results: A nonsense mutation causing a premature stop codon in a novel gene (cereblon; CRBN) was identified that encodes for an ATP-dependent Lon protease. The predicted protein sequence is highly conserved across species, and it belongs to a family of proteins that selectively degrade short-lived polypeptides and regulate mitochondrial replication and transcription. One member of the Lon-containing protein family is regionally expressed in the human hippocampus, an important neuroanatomic region that is involved in long-term potentiation and learning. The mutation in the CRBN gene described interrupts an N-myristoylation site and eliminates a casein kinase II phosphorylation site at the C terminus. Conclusions: A gene on chromosome 3p that is associated with mild mental retardation in a large kindred is reported. This finding implicates a role for the ATP-dependent degradation of proteins in memory and learning.

1 July 2012 in RNA Biology
Verified
Journal Article
Closed access
PDF file
APAshish Patil
Ashish Patil
CCClement Chan
Clement Chan
MDMadhu Dyavaiah
Madhu Dyavaiah
JRJohn P. Rooney
John P. Rooney
Peter DedonPeter Dedon
Peter Dedon
TBThomas Begley
Thomas Begley
Correct codon-anticodon pairing promotes translational fidelity, with these interactions greatly facilitated by modified nucleosides found in tRNA. We hypothesized that wobble uridine modifications catalyzed by tRNA methyltransferase 9 (Trm9) are essential for translational fidelity. In support, we have used phenotypic, reporter and protein-based assays to demonstrate increased translational infidelity in trm9Δ Saccharomyces cerevisiae cells. Codon reengineering studies suggest that Trm9-catalyzed tRNA modifications promote fidelity during the translation of specific genes, those rich in arginine and glutamic acid codons from mixed boxes. Using quantitative tRNA modification analysis, we determined that trm9Δ cells are only deficient in 2 of 23 tRNA modifications, with those 2, 5-methoxycarbonylmethyluridine (mcm5U) and 5-methoxycarbonylmethyl-2-thiouridine (mcm5s2U), classified as key determinants of translational fidelity. We also show that in the absence of mcm5U and mcm5s2U, the resulting translational infidelity promotes protein errors and activation of unfolded protein and heat shock responses. These data support a model in which Trm9-catalyzed tRNA modifications promote fidelity during the translation of specific transcripts, with decreased wobble base modification leading to translational infidelity, protein errors and activation of protein stress response pathways.

24 June 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ALAnthony L. Luz
Anthony L. Luz
JRJohn P. Rooney
John P. Rooney
LKLaura L. Kubik
Laura L. Kubik
CGClaudia P. Gonzalez
Claudia P. Gonzalez
DSDong Hoon Song
Dong Hoon Song
JMJoel N. Meyer
Joel N. Meyer
Mitochondrial dysfunction has been linked to myriad human diseases and toxicant exposures, highlighting the need for assays capable of rapidly assessing mitochondrial health in vivo. Here, using the Seahorse XFe24 Analyzer and the pharmacological inhibitors dicyclohexylcarbodiimide and oligomycin (ATP-synthase inhibitors), carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (mitochondrial uncoupler) and sodium azide (cytochrome c oxidase inhibitor), we measured the fundamental parameters of mitochondrial respiratory chain function: basal oxygen consumption, ATP-linked respiration, maximal respiratory capacity, spare respiratory capacity and proton leak in the model organism Caenhorhabditis elegans. Since mutations in mitochondrial homeostasis genes cause mitochondrial dysfunction and have been linked to human disease, we measured mitochondrial respiratory function in mitochondrial fission (drp-1)-, fusion (fzo-1)-, mitophagy (pdr-1, pink-1)-, and electron transport chain complex III (isp-1)-deficient C. elegans. All showed altered function, but the nature of the alterations varied between the tested strains. We report increased basal oxygen consumption in drp-1; reduced maximal respiration in drp-1, fzo-1, and isp-1; reduced spare respiratory capacity in drp-1 and fzo-1; reduced proton leak in fzo-1 and isp-1; and increased proton leak in pink-1 nematodes. As mitochondrial morphology can play a role in mitochondrial energetics, we also quantified the mitochondrial aspect ratio for each mutant strain using a novel method, and for the first time report increased aspect ratios in pdr-1- and pink-1-deficient nematodes.